Investigating the molecular mechanisms underlying the co-occurrence of Parkinson’s disease and inflammatory bowel disease through the integration of multiple datasets
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Investigating the molecular mechanisms underlying the co-occurrence of Parkinson’s disease and inflammatory bowel disease through the integration of multiple datasets ; volume:14 ; number:1 ; day:24 ; month:7 ; year:2024 ; pages:1-14 ; date:12.2024
Scientific reports ; 14, Heft 1 (24.7.2024), 1-14, 12.2024
- Creator
-
Sun, Qi
Li, Yi-Jun
Ning, Shou-Bin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-67890-1
- URN
-
urn:nbn:de:101:1-2410100716177.302611301550
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sun, Qi
- Li, Yi-Jun
- Ning, Shou-Bin
- SpringerLink (Online service)
Other Objects (12)
Quantitative validation of CFD simulations of blood flow in cerebral aneurysms : in-vitro and in-vivo investigations
Discovering genetic mechanisms underlying the co-occurrence of Parkinson’s disease and non-motor traits
The heterogeneity of Parkinson’s disease
The immunology of Parkinson’s disease
Brait-Fahn-Schwartz Disease: A Unique Co-Occurrence of Parkinson’s Disease and Amyotrophic Lateral Sclerosis
Anatomical correlates of apathy and impulsivity co-occurrence in early Parkinson’s disease
A Finite Element Method for Two-Phase Flow with Material Viscous Interface
PDON: Parkinson’s disease ontology for representation and modeling of the Parkinson’s disease knowledge domain
Responsiveness of the short-form health survey and the Parkinson’s disease questionnaire in patients with Parkinson’s disease
The neurophysiological brain-fingerprint of Parkinson’s disease
Cannabinoids in the Treatment of Parkinson’s Disease
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Quantitative validation of CFD simulations of blood flow in cerebral aneurysms : in-vitro and in-vivo investigations
Discovering genetic mechanisms underlying the co-occurrence of Parkinson’s disease and non-motor traits
The heterogeneity of Parkinson’s disease
The immunology of Parkinson’s disease
Brait-Fahn-Schwartz Disease: A Unique Co-Occurrence of Parkinson’s Disease and Amyotrophic Lateral Sclerosis
Anatomical correlates of apathy and impulsivity co-occurrence in early Parkinson’s disease
A Finite Element Method for Two-Phase Flow with Material Viscous Interface
PDON: Parkinson’s disease ontology for representation and modeling of the Parkinson’s disease knowledge domain
Responsiveness of the short-form health survey and the Parkinson’s disease questionnaire in patients with Parkinson’s disease
The neurophysiological brain-fingerprint of Parkinson’s disease
Cannabinoids in the Treatment of Parkinson’s Disease
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Quantitative validation of CFD simulations of blood flow in cerebral aneurysms : in-vitro and in-vivo investigations
Discovering genetic mechanisms underlying the co-occurrence of Parkinson’s disease and non-motor traits
The heterogeneity of Parkinson’s disease
The immunology of Parkinson’s disease
Brait-Fahn-Schwartz Disease: A Unique Co-Occurrence of Parkinson’s Disease and Amyotrophic Lateral Sclerosis
Anatomical correlates of apathy and impulsivity co-occurrence in early Parkinson’s disease
A Finite Element Method for Two-Phase Flow with Material Viscous Interface
PDON: Parkinson’s disease ontology for representation and modeling of the Parkinson’s disease knowledge domain
Responsiveness of the short-form health survey and the Parkinson’s disease questionnaire in patients with Parkinson’s disease
The neurophysiological brain-fingerprint of Parkinson’s disease
Cannabinoids in the Treatment of Parkinson’s Disease